We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 124

Connecticut reaffirms learned intermediary doctrine
  • Epstein Becker Green
  • USA
  • November 1 2011

Sunovion Pharmaceuticals obtained summary judgment on October 5, 2011 after oral argument before the Hon. Stefan R. Underhill in federal court in Bridgeport, Connecticut in the case of Swoverland v. GlaxoSmithKline, No. 3:10cv-914.

Connecticut requires drug and device manufacturers to adopt a code of conduct and compliance program by January 1, 2011
  • Arnall Golden Gregory LLP
  • USA
  • October 11 2010

The governor of Connecticut has signed into law Senate Bill 428 that requires pharmaceutical and medical device manufacturers to implement, at a minimum, the Pharmaceutical Research and Manufacturers of America's "Code on Interactions with Healthcare Professionals" (the PhRMA Code) or the Advanced Medical Technology Association's "Code of Ethics on Interactions with Health Care Professionals" (the AdvaMed Code) on or before January 1, 2011.

Connecticut enacts law requiring drug and device manufacturers to adopt compliance program
  • Sidley Austin LLP
  • USA
  • June 15 2010

On June 8th, Connecticut enacted into law Senate Bill 428, which, among other provisions, requires pharmaceutical and medical device manufacturers to adopt compliance programs by January 1, 2011.